173 related articles for article (PubMed ID: 28319380)
1. Evaluation and Characterization of Trk Kinase Inhibitors for the Treatment of Pain: Reliable Binding Affinity Predictions from Theory and Computation.
Wan S; Bhati AP; Skerratt S; Omoto K; Shanmugasundaram V; Bagal SK; Coveney PV
J Chem Inf Model; 2017 Apr; 57(4):897-909. PubMed ID: 28319380
[TBL] [Abstract][Full Text] [Related]
2. Rapid and Reliable Binding Affinity Prediction of Bromodomain Inhibitors: A Computational Study.
Wan S; Bhati AP; Zasada SJ; Wall I; Green D; Bamborough P; Coveney PV
J Chem Theory Comput; 2017 Feb; 13(2):784-795. PubMed ID: 28005370
[TBL] [Abstract][Full Text] [Related]
3. The performance of ensemble-based free energy protocols in computing binding affinities to ROS1 kinase.
Wan S; Bhati AP; Wright DW; Wade AD; Tresadern G; van Vlijmen H; Coveney PV
Sci Rep; 2022 Jun; 12(1):10433. PubMed ID: 35729177
[TBL] [Abstract][Full Text] [Related]
4. Structural Optimization and Structure-Activity Relationship Studies of 6,6-Dimethyl-4-(phenylamino)-6
Pan S; Zhang L; Luo X; Nan J; Yang W; Bin H; Li Y; Huang Q; Wang T; Pan Z; Mu B; Wang F; Tian C; Liu Y; Li L; Yang S
J Med Chem; 2022 Feb; 65(3):2035-2058. PubMed ID: 35080890
[TBL] [Abstract][Full Text] [Related]
5. Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation.
Yan W; Zhang L; Lv F; Moccia M; Carlomagno F; Landry C; Santoro M; Gosselet F; Frett B; Li HY
Eur J Med Chem; 2021 Apr; 216():113265. PubMed ID: 33652352
[TBL] [Abstract][Full Text] [Related]
6. Ensemble Simulations and Experimental Free Energy Distributions: Evaluation and Characterization of Isoxazole Amides as SMYD3 Inhibitors.
Wan S; Bhati AP; Wright DW; Wall ID; Graves AP; Green D; Coveney PV
J Chem Inf Model; 2022 May; 62(10):2561-2570. PubMed ID: 35508076
[TBL] [Abstract][Full Text] [Related]
7. Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application.
Yan W; Lakkaniga NR; Carlomagno F; Santoro M; McDonald NQ; Lv F; Gunaganti N; Frett B; Li HY
J Med Chem; 2019 Feb; 62(4):1731-1760. PubMed ID: 30188734
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of nonactive site, TrkA-selective kinase inhibitors.
Su HP; Rickert K; Burlein C; Narayan K; Bukhtiyarova M; Hurzy DM; Stump CA; Zhang X; Reid J; Krasowska-Zoladek A; Tummala S; Shipman JM; Kornienko M; Lemaire PA; Krosky D; Heller A; Achab A; Chamberlin C; Saradjian P; Sauvagnat B; Yang X; Ziebell MR; Nickbarg E; Sanders JM; Bilodeau MT; Carroll SS; Lumb KJ; Soisson SM; Henze DA; Cooke AJ
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E297-E306. PubMed ID: 28039433
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimization.
Li MC; Lin WH; Wang PC; Su YC; Chen PY; Fan CM; Chen CP; Huang CL; Chiu CH; Chang L; Chen CT; Yeh TK; Hsieh HP
Eur J Med Chem; 2021 Nov; 224():113673. PubMed ID: 34303872
[TBL] [Abstract][Full Text] [Related]
10. A novel in-cell ELISA method for screening of compounds inhibiting TRKA phosphorylation, using KM12 cell line harboring TRKA rearrangement.
Pandre MK; Shaik S; Satya Pratap VVV; Yadlapalli P; Yanamandra M; Mitra S
Anal Biochem; 2018 Mar; 545():78-83. PubMed ID: 29360440
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition.
Bernard-Gauthier V; Schirrmacher R
Expert Opin Ther Pat; 2016; 26(2):291-5. PubMed ID: 26561352
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological activity of bicyclic carboxamide derivatives as TRK inhibitors.
Sun M; Cai S; Li P; Zhang F; Zhang H; Zhou J
Bioorg Med Chem; 2020 Dec; 28(23):115811. PubMed ID: 33069129
[TBL] [Abstract][Full Text] [Related]
13. Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.
Bailey JJ; Schirrmacher R; Farrell K; Bernard-Gauthier V
Expert Opin Ther Pat; 2017 Jun; 27(6):733-751. PubMed ID: 28270010
[TBL] [Abstract][Full Text] [Related]
14. Trk kinase inhibitors as new treatments for cancer and pain.
Wang T; Yu D; Lamb ML
Expert Opin Ther Pat; 2009 Mar; 19(3):305-19. PubMed ID: 19441906
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel TrkA allosteric inhibitors: Structure-based virtual screening, biological evaluation and preliminary SAR studies.
Guo J; Xiang S; Wang J; Zhou Y; Wang Z; Zhang Z; Ding K; Lu X
Eur J Med Chem; 2022 Jan; 228():114022. PubMed ID: 34871843
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and SAR of substituted indoles as selective TrkA inhibitors.
Hurzy DM; Henze DA; Cabalu TD; Narayan K; Heller A; Cooke AJ
Bioorg Med Chem Lett; 2017 Jun; 27(12):2695-2701. PubMed ID: 28465100
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and Structure-Activity Relationships (SAR) of 3-vinylindazole derivatives as new selective tropomyosin receptor kinases (Trk) inhibitors.
Duan Y; Wang J; Zhu S; Tu ZC; Zhang Z; Chan S; Ding K
Eur J Med Chem; 2020 Oct; 203():112552. PubMed ID: 32702585
[TBL] [Abstract][Full Text] [Related]
18. Discovery of First-In-Class Potent and Selective Tropomyosin Receptor Kinase Degraders.
Chen L; Chen Y; Zhang C; Jiao B; Liang S; Tan Q; Chai H; Yu W; Qian Y; Yang H; Yao W; Yu J; Luo Y; Plewe M; Wang J; Han XR; Liu J
J Med Chem; 2020 Dec; 63(23):14562-14575. PubMed ID: 33058680
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase Inhibitors.
Bagal SK; Omoto K; Blakemore DC; Bungay PJ; Bilsland JG; Clarke PJ; Corbett MS; Cronin CN; Cui JJ; Dias R; Flanagan NJ; Greasley SE; Grimley R; Johnson E; Fengas D; Kitching L; Kraus ML; McAlpine I; Nagata A; Waldron GJ; Warmus JS
J Med Chem; 2019 Jan; 62(1):247-265. PubMed ID: 29672039
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain.
Bagal SK; Andrews M; Bechle BM; Bian J; Bilsland J; Blakemore DC; Braganza JF; Bungay PJ; Corbett MS; Cronin CN; Cui JJ; Dias R; Flanagan NJ; Greasley SE; Grimley R; James K; Johnson E; Kitching L; Kraus ML; McAlpine I; Nagata A; Ninkovic S; Omoto K; Scales S; Skerratt SE; Sun J; Tran-Dubé M; Waldron GJ; Wang F; Warmus JS
J Med Chem; 2018 Aug; 61(15):6779-6800. PubMed ID: 29944371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
